<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33919324</PMID><DateRevised><Year>2021</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">741</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics11050741</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dengue virus (DENV) infection remains a global public health concern. Enzyme-linked immunosorbent assays (ELISAs), which detect antibodies targeting the envelope (E) protein of DENV, serve as the front-line serological test for presumptive dengue diagnosis. Very few studies have determined the serostatus by detecting antibodies targeting the nonstructural protein 1 (NS1), which can function as diagnostic biomarkers to distinguish natural immunity from vaccine-induced immunity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used community-acquired human serum specimens, with the serostatus confirmed by focus reduction microneutralization test (FR&#x3bc;NT), to evaluate the diagnostic performances of two NS1-based ELISA methods, namely, immunoglobulin G antibody-capture ELISA (NS1 GAC-ELISA) and indirect NS1 IgG ELISA, and compared the results with an E-based virus-like particle (VLP) GAC-ELISA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">NS1-based methods had comparable accuracies as VLP GAC-ELISA. Although the sensitivity in detecting anti-NS1 IgM was poor, indirect NS1 IgG ELISA showed similar limits of detection (~1-2 ng/mL) as NS1 GAC-ELISA in detecting anti-NS1 IgG. Combining the results from two or more tests as a composite reference standard can determine the DENV serostatus with a specificity reaching 100%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">NS1-based ELISAs have comparable accuracies as VLP GAC-ELISA in determining dengue serostatus, which could effectively assist clinicians during assessments of vaccine eligibility.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galula</LastName><ForeName>Jedhan Ucat</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Gielenny M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Destura</LastName><ForeName>Raul V</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biotechnology, National Institutes of Health, University of the Philippines Manila, Manila 1000, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remenyi</LastName><ForeName>Roland</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1644-6464</Identifier><AffiliationInfo><Affiliation>Biomedical Research Unit, Clinical and Translational Research Institute, The Medical City, Pasig 1605, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Day-Yu</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0001-7139-026X</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOST-107-2923-B-005-005-MY3</GrantID><Agency>Ministry of Science and Technology, Taiwan</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">E protein</Keyword><Keyword MajorTopicYN="N">GAC&#x2013;ELISA</Keyword><Keyword MajorTopicYN="N">NS1 protein</Keyword><Keyword MajorTopicYN="N">composite reference standard</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">indirect IgG ELISA</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33919324</ArticleId><ArticleId IdType="pmc">PMC8143319</ArticleId><ArticleId IdType="doi">10.3390/diagnostics11050741</ArticleId><ArticleId IdType="pii">diagnostics11050741</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lindenbach B.D.M., Murray C.L., Thiel H., Rice C.M. Flaviviridae. In: Knipe D.M., Howley P.M., editors. Fields Virology. 6th ed. Lippincott Williams &amp; Wilkins; Philadelphia, PA, USA: 2007. pp. 712&#x2013;746.</Citation></Reference><Reference><Citation>Calisher C.H., Karabatsos N., Dalrymple J.M., Shope R.E., Porterfield J.S., Westaway E.G., Brandt W.E. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. Pt 1J. Gen. Virol. 1989;70:37&#x2013;43. doi: 10.1099/0022-1317-70-1-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-70-1-37</ArticleId><ArticleId IdType="pubmed">2543738</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Dengue. Lancet. 2007;370:1644&#x2013;1652. doi: 10.1016/S0140-6736(07)61687-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61687-0</ArticleId><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle J.L., Harris E. Global spread and persistence of dengue. Annu. Rev. Microbiol. 2008;62:71&#x2013;92. doi: 10.1146/annurev.micro.62.081307.163005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.62.081307.163005</ArticleId><ArticleId IdType="pubmed">18429680</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., Hunsperger E., Kroeger A., Margolis H.S., Martinez E., et al. Dengue: A continuing global threat. Nat. Rev. Microbiol. 2010;8:S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa T., Yamanaka A., Konishi E. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine. 2014;32:1326&#x2013;1337. doi: 10.1016/j.vaccine.2014.01.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.01.040</ArticleId><ArticleId IdType="pubmed">24486372</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M.H., Metz S.W. Progress and works in progress: Update on flavivirus vaccine development. Clin. Ther. 2017;39:1519&#x2013;1536. doi: 10.1016/j.clinthera.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2017.07.001</ArticleId><ArticleId IdType="pubmed">28754189</ArticleId></ArticleIdList></Reference><Reference><Citation>Galula J.U., Salem G.M., Chang G.J., Chao D.Y. Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era? Hum. Vaccin. Immunother. 2019;15:2328&#x2013;2336. doi: 10.1080/21645515.2019.1643676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1643676</ArticleId><ArticleId IdType="pmc">PMC6816432</ArticleId><ArticleId IdType="pubmed">31314657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990;44:649&#x2013;688. doi: 10.1146/annurev.mi.44.100190.003245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.44.100190.003245</ArticleId><ArticleId IdType="pubmed">2174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller D.A., Young P.R. The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antivir. Res. 2013;98:192&#x2013;208. doi: 10.1016/j.antiviral.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.008</ArticleId><ArticleId IdType="pubmed">23523765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach B.D., Rice C.M. Molecular biology of flaviviruses. Adv. Virus Res. 2003;59:23&#x2013;61. doi: 10.1016/s0065-3527(03)59002-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0065-3527(03)59002-9</ArticleId><ArticleId IdType="pubmed">14696326</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger J.J., Brandriss M.W., Walsh E.E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. Pt 3J. Gen. Virol. 1987;68:853&#x2013;857. doi: 10.1099/0022-1317-68-3-853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-68-3-853</ArticleId><ArticleId IdType="pubmed">3819700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W., Jumnainsong A., Onsirisakul N., Fitton P., Vasanawathana S., Limpitikul W., Puttikhunt C., Edwards C., Duangchinda T., Supasa S., et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745&#x2013;748. doi: 10.1126/science.1185181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1185181</ArticleId><ArticleId IdType="pmc">PMC3837288</ArticleId><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal E.A., Henchal L.S., Schlesinger J.J. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. Pt 8J. Gen. Virol. 1988;69:2101&#x2013;2107. doi: 10.1099/0022-1317-69-8-2101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-69-8-2101</ArticleId><ArticleId IdType="pubmed">3404125</ArticleId></ArticleIdList></Reference><Reference><Citation>Albinsson B., Vene S., Rombo L., Blomberg J., Lundkvist A., Ronnberg B. Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017. Euro Surveill. 2018;23 doi: 10.2807/1560-7917.ES.2018.23.3.17-00838.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.3.17-00838</ArticleId><ArticleId IdType="pmc">PMC5792698</ArticleId><ArticleId IdType="pubmed">29386094</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi E., Suzuki T. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: Evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations. Vaccine. 2002;21:98&#x2013;107. doi: 10.1016/S0264-410X(02)00433-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(02)00433-4</ArticleId><ArticleId IdType="pubmed">12443667</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi E. Status of natural infection with Japanese encephalitis virus in Japan: Prevalence of antibodies to the nonstructural 1 protein among humans and horses. Vaccine. 2009;27:7129&#x2013;7130. doi: 10.1016/j.vaccine.2009.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.09.052</ArticleId><ArticleId IdType="pubmed">19799840</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu P.Y., Chen L.K., Chang S.F., Yueh Y.Y., Chow L., Chien L.J., Chin C., Lin T.H., Huang J.H. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: Potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine. 2001;19:1753&#x2013;1763. doi: 10.1016/S0264-410X(00)00391-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(00)00391-1</ArticleId><ArticleId IdType="pubmed">11166901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman A.L. Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 2011;11:532&#x2013;543. doi: 10.1038/nri3014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3014</ArticleId><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento E.J.M., George J.K., Velasco M., Bonaparte M.I., Zheng L., DiazGranados C.A., Marques E.T.A., Huleatt J.W. Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus. J. Virol. Methods. 2018;257:48&#x2013;57. doi: 10.1016/j.jviromet.2018.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2018.03.007</ArticleId><ArticleId IdType="pubmed">29567514</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento E.J.M., Huleatt J.W., Cordeiro M.T., Castanha P.M.S., George J.K., Grebe E., Welte A., Brown M., Burke D.S., Marques E.T.A. Development of antibody biomarkers of long term and recent dengue virus infections. J. Virol. Methods. 2018;257:62&#x2013;68. doi: 10.1016/j.jviromet.2018.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2018.04.009</ArticleId><ArticleId IdType="pubmed">29684416</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu P.Y., Chen L.K., Chang S.F., Yueh Y.Y., Chow L., Chien L.J., Chin C., Yang H.H., Lin T.H., Huang J.H. Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: Correlation of results with those of the plaque reduction neutralization test. J. Clin. Microbiol. 2002;40:1840&#x2013;1844. doi: 10.1128/JCM.40.5.1840-1844.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.5.1840-1844.2002</ArticleId><ArticleId IdType="pmc">PMC130672</ArticleId><ArticleId IdType="pubmed">11980973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyson J., Tsai W.Y., Tsai J.J., Brites C., Massgard L., Ha Youn H., Pedroso C., Drexler J.F., Stramer S.L., Balmaseda A., et al. Combination of nonstructural protein 1-based enzyme-linked immunosorbent assays can detect and distinguish various dengue virus and zika virus infections. J. Clin. Microbiol. 2019;57 doi: 10.1128/JCM.01464-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01464-18</ArticleId><ArticleId IdType="pmc">PMC6355536</ArticleId><ArticleId IdType="pubmed">30429254</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu P.Y., Chen L.K., Chang S.F., Yueh Y.Y., Chow L., Chien L.J., Chin C., Lin T.H., Huang J.H. Dengue NS1-specific antibody responses: Isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 2000;62:224&#x2013;232. doi: 10.1002/1096-9071(200010)62:2&lt;224::AID-JMV14&gt;3.0.CO;2-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200010)62:2&lt;224::AID-JMV14&gt;3.0.CO;2-C</ArticleId><ArticleId IdType="pubmed">11002252</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi E., Shoda M., Ajiro N., Kondo T. Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses. J. Clin. Microbiol. 2004;42:5087&#x2013;5093. doi: 10.1128/JCM.42.11.5087-5093.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.42.11.5087-5093.2004</ArticleId><ArticleId IdType="pmc">PMC525176</ArticleId><ArticleId IdType="pubmed">15528700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu P.Y., Chen L.K., Chang S.F., Su C.L., Chien L.J., Chin C., Lin T.H., Huang J.H. Dengue virus serotyping based on envelope and membrane and nonstructural protein NS1 serotype-specific capture immunoglobulin M enzyme-linked immunosorbent assays. J. Clin. Microbiol. 2004;42:2489&#x2013;2494. doi: 10.1128/JCM.42.6.2489-2494.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.42.6.2489-2494.2004</ArticleId><ArticleId IdType="pmc">PMC427809</ArticleId><ArticleId IdType="pubmed">15184425</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao D.Y., Galula J.U., Shen W.F., Davis B.S., Chang G.J. Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans. J. Clin. Microbiol. 2015;53:557&#x2013;566. doi: 10.1128/JCM.02735-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02735-14</ArticleId><ArticleId IdType="pmc">PMC4298564</ArticleId><ArticleId IdType="pubmed">25502522</ArticleId></ArticleIdList></Reference><Reference><Citation>Galula J.U., Chang G.J., Chuang S.T., Chao D.Y. Establishment of an algorithm using prM/E- and NS1-specific IgM antibody-capture enzyme-linked immunosorbent assays in diagnosis of Japanese encephalitis virus and West Nile virus infections in humans. J. Clin. Microbiol. 2016;54:412&#x2013;422. doi: 10.1128/JCM.02469-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02469-15</ArticleId><ArticleId IdType="pmc">PMC4733197</ArticleId><ArticleId IdType="pubmed">26659204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao D.Y., Whitney M.T., Davis B.S., Medina F.A., Munoz J.L., Chang G.J. Comprehensive evaluation of differential serodiagnosis between zika and dengue viral infections. J. Clin. Microbiol. 2019;57 doi: 10.1128/JCM.01506-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01506-18</ArticleId><ArticleId IdType="pmc">PMC6425182</ArticleId><ArticleId IdType="pubmed">30541932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.J., Hunt A.R., Holmes D.A., Springfield T., Chiueh T.S., Roehrig J.T., Gubler D.J. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology. 2003;306:170&#x2013;180. doi: 10.1016/S0042-6822(02)00028-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(02)00028-4</ArticleId><ArticleId IdType="pubmed">12620809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.J., Davis B.S., Stringfield C., Lutz C. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection. Vaccine. 2007;25:2325&#x2013;2330. doi: 10.1016/j.vaccine.2006.11.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2006.11.056</ArticleId><ArticleId IdType="pubmed">17224209</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes D.A., Purdy D.E., Chao D.Y., Noga A.J., Chang G.J. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J. Clin. Microbiol. 2005;43:3227&#x2013;3236. doi: 10.1128/JCM.43.7.3227-3236.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.7.3227-3236.2005</ArticleId><ArticleId IdType="pmc">PMC1169144</ArticleId><ArticleId IdType="pubmed">16000440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N., Gammell P., Clynes M. Proliferation control strategies to improve productivity and survival during CHO based production culture: A summary of recent methods employed and the effects of proliferation control in product secreting CHO cell lines. Cytotechnology. 2007;53:33&#x2013;46. doi: 10.1007/s10616-007-9047-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10616-007-9047-6</ArticleId><ArticleId IdType="pmc">PMC2267618</ArticleId><ArticleId IdType="pubmed">19003188</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill W.D., Hughes H.R., Delorey M.J., Chang G.J. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS ONE. 2009;4:e4991. doi: 10.1371/journal.pone.0004991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004991</ArticleId><ArticleId IdType="pmc">PMC2659788</ArticleId><ArticleId IdType="pubmed">19337372</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W.F., Galula J.U., Liu J.H., Liao M.Y., Huang C.H., Wang Y.C., Wu H.C., Liang J.J., Lin Y.L., Whitney M.T., et al. Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody. Elife. 2018;7 doi: 10.7554/eLife.38970.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.38970</ArticleId><ArticleId IdType="pmc">PMC6234032</ArticleId><ArticleId IdType="pubmed">30334522</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C.P., Semenova V.A., Elie C.M., Romero-Steiner S., Greene C., Li H., Stamey K., Steward-Clark E., Schmidt D.S., Mothershed E., et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis. 2002;8:1103&#x2013;1110. doi: 10.3201/eid0810.020380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0810.020380</ArticleId><ArticleId IdType="pmc">PMC2730307</ArticleId><ArticleId IdType="pubmed">12396924</ArticleId></ArticleIdList></Reference><Reference><Citation>Makela O., Karjalainen K. Inherited immunoglobulin idiotypes of the mouse. Immunol. Rev. 1977;34:119&#x2013;138. doi: 10.1111/j.1600-065X.1977.tb00370.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1977.tb00370.x</ArticleId><ArticleId IdType="pubmed">66781</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkirane N., Guichard G., Van Regenmortel M.H., Briand J.P., Muller S. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate-constant measurements. J. Biol. Chem. 1995;270:11921&#x2013;11926. doi: 10.1074/jbc.270.20.11921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.20.11921</ArticleId><ArticleId IdType="pubmed">7744843</ArticleId></ArticleIdList></Reference><Reference><Citation>Puschnik A., Lau L., Cromwell E.A., Balmaseda A., Zompi S., Harris E. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl. Trop. Dis. 2013;7:e2274. doi: 10.1371/journal.pntd.0002274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002274</ArticleId><ArticleId IdType="pmc">PMC3681624</ArticleId><ArticleId IdType="pubmed">23785536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.Y., Williams K.L., Wu Y.C., Knight S., Balmaseda A., Harris E., Wang W.K. Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl. Trop. Dis. 2013;7:e2451. doi: 10.1371/journal.pntd.0002451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002451</ArticleId><ArticleId IdType="pmc">PMC3777924</ArticleId><ArticleId IdType="pubmed">24069496</ArticleId></ArticleIdList></Reference><Reference><Citation>Raafat N., Blacksell S.D., Maude R.J. A review of dengue diagnostics and implications for surveillance and control. Trans. R. Soc. Trop. Med. Hyg. 2019;113:653&#x2013;660. doi: 10.1093/trstmh/trz068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trz068</ArticleId><ArticleId IdType="pmc">PMC6836713</ArticleId><ArticleId IdType="pubmed">31365115</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo R., Fongwen N., Kelly-Cirino C., Harris E., Wilder-Smith A., Peeling R.W. Rapid diagnostic tests for determining dengue serostatus: A systematic review and key informant interviews. Clin. Microbiol. Infect. 2019;25:659&#x2013;666. doi: 10.1016/j.cmi.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2019.01.002</ArticleId><ArticleId IdType="pmc">PMC6543064</ArticleId><ArticleId IdType="pubmed">30664935</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi E., Kitai Y. Detection by ELISA of antibodies to Japanese encephalitis virus nonstructural 1 protein induced in subclinically infected humans. Vaccine. 2009;27:7053&#x2013;7058. doi: 10.1016/j.vaccine.2009.09.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.09.064</ArticleId><ArticleId IdType="pubmed">19786140</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai W.Y., Youn H.H., Brites C., Tsai J.J., Tyson J., Pedroso C., Drexler J.F., Stone M., Simmons G., Busch M.P., et al. Distinguishing secondary dengue virus infection from zika virus infection with previous dengue by a combination of 3 simple serological tests. Clin. Infect. Dis. 2017;65:1829&#x2013;1836. doi: 10.1093/cid/cix672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix672</ArticleId><ArticleId IdType="pmc">PMC5850648</ArticleId><ArticleId IdType="pubmed">29020159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.J., Furuya A., Zou J., Xie X., Dupuis A.P., II, Kramer L.D., Shi P.Y. A multiplex microsphere immunoassay for zika virus diagnosis. EBioMedicine. 2017;16:136&#x2013;140. doi: 10.1016/j.ebiom.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5474433</ArticleId><ArticleId IdType="pubmed">28094237</ArticleId></ArticleIdList></Reference><Reference><Citation>De Alwis R., Beltramello M., Messer W.B., Sukupolvi-Petty S., Wahala W.M., Kraus A., Olivarez N.P., Pham Q., Brien J.D., Tsai W.Y., et al. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl. Trop. Dis. 2011;5:e1188. doi: 10.1371/annotation/f585335f-ff77-40ae-a8b6-ad6019af31aa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/f585335f-ff77-40ae-a8b6-ad6019af31aa</ArticleId><ArticleId IdType="pmc">PMC3119640</ArticleId><ArticleId IdType="pubmed">21713020</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltramello M., Williams K.L., Simmons C.P., Macagno A., Simonelli L., Quyen N.T., Sukupolvi-Petty S., Navarro-Sanchez E., Young P.R., de Silva A.M., et al. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8:271&#x2013;283. doi: 10.1016/j.chom.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC3884547</ArticleId><ArticleId IdType="pubmed">20833378</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy B., Jackson N. Dengue vaccine: Hypotheses to understand CYD-TDV-induced protection. Nat. Rev. Microbiol. 2016;14:45&#x2013;54. doi: 10.1038/nrmicro.2015.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2015.2</ArticleId><ArticleId IdType="pubmed">26639777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadinegoro S.R., Arredondo-Garcia J.L., Capeding M.R., Deseda C., Chotpitayasunondh T., Dietze R., Muhammad Ismail H.I., Reynales H., Limkittikul K., Rivera-Medina D.M., et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med. 2015;373:1195&#x2013;1206. doi: 10.1056/NEJMoa1506223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1506223</ArticleId><ArticleId IdType="pubmed">26214039</ArticleId></ArticleIdList></Reference><Reference><Citation>Capeding M.R., Tran N.H., Hadinegoro S.R., Ismail H.I., Chotpitayasunondh T., Chua M.N., Luong C.Q., Rusmil K., Wirawan D.N., Nallusamy R., et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384:1358&#x2013;1365. doi: 10.1016/S0140-6736(14)61060-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61060-6</ArticleId><ArticleId IdType="pubmed">25018116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Barraquer I., Mier Y.T.-R.L., Ferguson N., Burke D.S., Cummings D.A.T. Differential efficacy of dengue vaccine by immune status. Lancet. 2015;385:1726. doi: 10.1016/S0140-6736(15)60889-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60889-3</ArticleId><ArticleId IdType="pubmed">25943936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar S., Luedtke A., Langevin E., Zhu M., Bonaparte M., Machabert T., Savarino S., Zambrano B., Moureau A., Khromava A., et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N. Engl. J. Med. 2018;379:327&#x2013;340. doi: 10.1056/NEJMoa1800820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800820</ArticleId><ArticleId IdType="pubmed">29897841</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Dengue vaccine: WHO position paper, September 2018&#x2014;Recommendations. Vaccine. 2018;37:4848&#x2013;4849. doi: 10.1016/j.vaccine.2018.09.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.09.063</ArticleId><ArticleId IdType="pubmed">30424888</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Ooi E.E., Horstick O., Wills B. Dengue. Lancet. 2019;393:350&#x2013;363. doi: 10.1016/S0140-6736(18)32560-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32560-1</ArticleId><ArticleId IdType="pubmed">30696575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Smith P.G., Luo R., Kelly-Cirino C., Curry D., Larson H., Durbin A., Chu M., Tharmaphornpilas P., Ng L.C., et al. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine. 2019;37:5137&#x2013;5146. doi: 10.1016/j.vaccine.2019.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.016</ArticleId><ArticleId IdType="pubmed">31377079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez A.L., Adams C., Ylade M., Jadi R., Daag J.V., Molloy C.T., Agrupis K.A., Kim D.R., Silva M.W., Yoon I.K., et al. Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: A prospective population-based study. Lancet Glob. Health. 2021;9:e44&#x2013;e51. doi: 10.1016/S2214-109X(20)30392-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30392-2</ArticleId><ArticleId IdType="pubmed">33212030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosack C.S., Page A.L., Klatser P.R. A guide to aid the selection of diagnostic tests. Bull. World Health Organ. 2017;95:639&#x2013;645. doi: 10.2471/BLT.16.187468.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.16.187468</ArticleId><ArticleId IdType="pmc">PMC5578377</ArticleId><ArticleId IdType="pubmed">28867844</ArticleId></ArticleIdList></Reference><Reference><Citation>Land K.J., Boeras D.I., Chen X.S., Ramsay A.R., Peeling R.W. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat. Microbiol. 2019;4:46&#x2013;54. doi: 10.1038/s41564-018-0295-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0295-3</ArticleId><ArticleId IdType="pmc">PMC7097043</ArticleId><ArticleId IdType="pubmed">30546093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>